Healthcare organizations have a financial incentive to deliver value-based care throughout the entire patient journey. Proactive patient engagement supports this delivery model in several ways.
Learn More
Pharmacovigilance expert Bart Cobert examines the issues associated with language translation in PV and drug safety.
Digital healthcare has only now begun to genuinely transform patient experience. These 6 major trends will drive the patient experience in 2018.
Bart Cobert highlights the ongoing saga with EMA and Brexit. In this post, he elaborates on the lack of a current Brexit deal between the EU and the UK.
There are 3 keys to success when developing a patient engagement program.
Nurses today are in an optimal position to help pharma companies. Dr. Adele Mueller shares how empowering nurses empowers patients.
Another update from Bart Cobert regarding the ongoing Brexit saga.
The Brexit saga continues. Here Bart Cobert highlights new Brexit developments with regard to the EMA.
Bart Cobert examines the importance of, and differences between Data Monitoring Committees (DMCs) & Safety Assessment Committees (SACs).
How have Millennial channel preferences for contacting consumer affairs changed over the past 5 years?
Bart Cobert reviews the key requirements for the US-EU Privacy Shield, including implications for US Firms, Pharma Companies, and Drug Safety & Pharmacovigilance
Exploring the role of the Medical Monitor in the clinical research process.
